Literature DB >> 14870886

Beyond the membrane--the role of new PD solutions in enhancing global biocompatibility.

Roberto Pecoits-Filho1, Peter Stenvinkel, Olof Heimbürger, Bengt Lindholm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14870886     DOI： 10.1046/j.1523-1755.2003.08814.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN： 0098-6577            Impact factor:   10.545


× No keyword cloud information.
  2 in total

1.  Rationale and design of the balANZ trial: a randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal function.

Authors:  David W Johnson; Margaret Clarke; Vanessa Wilson; Feidhlim Woods; Fiona G Brown
Journal:  BMC Nephrol       Date:  2010-09-16       Impact factor: 2.388

2.  The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial.

Authors:  David W Johnson; Fiona G Brown; Margaret Clarke; Neil Boudville; Tony J Elias; Marjorie W Y Foo; Bernard Jones; Hemant Kulkarni; Robyn Langham; Dwarakanathan Ranganathan; John Schollum; Michael G Suranyi; Seng H Tan; David Voss
Journal:  Nephrol Dial Transplant       Date:  2012-08-01       Impact factor: 5.992
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.